Articles by Lisa Harding, MD
Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
Esketamine for Treatment-Resistant Depression: Patient Selection Criteria
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
Intranasal Esketamine for Treatment-Resistant Depression
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
Current Guidelines for Managing Treatment-Resistant Depression
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
IV Ketamine for Treatment-Resistant Depression
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
Prevalence of Treatment-Resistant Depression
BySteven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP,Lisa Harding, MD,Patricia Ares-Romero, MD, FASAM Custom ViewPoints Video Program
